The patient mortality rate is greater than 85%, although it drops to as low as 40% in patients with recanalization. One can expect good functional outcomes in as few as 24 to 35% of patients treated with intravenous or intra-arterial thrombolysis. For symptomatic patients who survive, the risk of recurrent stroke is 10 to 15%.